Current Radiopharmaceuticals

Scope & Guideline

Exploring innovative applications in nuclear medicine.

Introduction

Welcome to the Current Radiopharmaceuticals information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Current Radiopharmaceuticals, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1874-4710
PublisherBENTHAM SCIENCE PUBL LTD
Support Open AccessNo
CountryUnited Arab Emirates
TypeJournal
Convergefrom 2009 to 2024
AbbreviationCURR RADIOPHARM / Curr. Radiopharm.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressEXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES

Aims and Scopes

Current Radiopharmaceuticals focuses on the intersection of radiopharmaceutical science, nuclear medicine, and therapeutic applications, providing critical insights into the development and application of radiopharmaceuticals in medical diagnostics and treatment.
  1. Radiopharmaceutical Development:
    The journal emphasizes the synthesis, characterization, and optimization of radiopharmaceuticals, including novel radiolabeling techniques and formulations for improved diagnostic and therapeutic efficacy.
  2. Radiotherapy and Radiosensitization:
    Research on enhancing the effectiveness of radiation therapy through radiosensitizers, exploring mechanisms of action, and evaluating therapeutic outcomes in various cancer types.
  3. Multimodal Imaging Techniques:
    A focus on the integration of different imaging modalities (e.g., PET, CT, SPECT) to enhance diagnostic accuracy and treatment monitoring, including the development of new imaging agents.
  4. Theranostics and Personalized Medicine:
    The journal explores theranostic approaches that combine diagnostics and therapeutics, highlighting the potential for personalized treatment strategies in oncology and other diseases.
  5. Radiobiology and Safety:
    Research on the biological effects of radiation, including protective measures against radiation-induced damage and the assessment of radiation safety in clinical practices.
Current Radiopharmaceuticals is witnessing several emerging themes that reflect the evolving landscape of radiopharmaceutical research and its applications in medicine.
  1. Nanotechnology in Radiopharmaceuticals:
    The integration of nanotechnology into radiopharmaceutical development is gaining traction, with studies focusing on nanoparticle-based delivery systems and their therapeutic applications in oncology.
  2. Targeted Radiotherapy Approaches:
    Emerging research on targeted radiotherapy, including the use of specific ligands for selective delivery of radiopharmaceuticals to tumor cells, is becoming increasingly prominent.
  3. Innovative Imaging Techniques:
    There is a growing interest in developing and validating advanced imaging techniques, such as hybrid imaging modalities and novel radiotracers, to improve diagnostic accuracy and treatment planning.
  4. Radioprotective Agents and Strategies:
    Research into agents that can protect healthy tissues from radiation damage is on the rise, highlighting the importance of improving patient safety during radiation therapies.
  5. Clinical Applications of Artificial Intelligence:
    The application of AI and machine learning in optimizing radiopharmaceutical production, imaging analysis, and treatment planning is emerging as a significant trend, indicating a shift towards technology-driven solutions.

Declining or Waning

While Current Radiopharmaceuticals has a diverse range of research topics, certain areas of focus appear to be declining in prominence based on recent publications.
  1. Traditional Radiopharmaceuticals:
    There is a noticeable decline in research related to conventional radiopharmaceuticals that do not incorporate novel elements or advanced methodologies, suggesting a shift toward more innovative approaches.
  2. General Reviews without New Data:
    The number of purely review articles summarizing existing knowledge without presenting new data or insights seems to be decreasing, indicating a preference for original research findings.
  3. Basic Radiobiological Studies:
    Research focusing solely on fundamental radiobiological mechanisms without direct clinical or translational applications appears to be less frequently published, reflecting a trend towards practical applications in clinical settings.

Similar Journals

CLINICAL NUCLEAR MEDICINE

Exploring the Frontiers of Diagnostic and Therapeutic Nuclear Medicine
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0363-9762Frequency: 12 issues/year

CLINICAL NUCLEAR MEDICINE is a premier journal dedicated to the field of nuclear medicine, published by Lippincott Williams & Wilkins. With a history of excellence since its inception in 1978, the journal serves as a vital resource for researchers, healthcare professionals, and students seeking to deepen their understanding of this rapidly evolving discipline. The journal holds a commendable Q2 ranking in both Medicine (miscellaneous) and Radiology, Nuclear Medicine and Imaging, reflecting its significant impact on advancing clinical practices and research. While currently not offered as an open-access publication, CLINICAL NUCLEAR MEDICINE ensures rigorous peer review and high-quality publications, contributing to the broad dissemination of cutting-edge studies and reviews. With its comprehensive scope encompassing both diagnostic and therapeutic nuclear medicine applications, researchers around the globe turn to this journal to stay informed and inspire innovations in patient care for the years leading up to 2024 and beyond.

Tomography

Bridging the gap between research and clinical application.
Publisher: MDPIISSN: 2379-1381Frequency: 6 issues/year

Tomography is an esteemed peer-reviewed journal published by MDPI, focusing on a broad spectrum of topics related to medical imaging and diagnostics. Launched in 2015, this Open Access journal serves as a vital platform for researchers, professionals, and students in the fields of medicine, radiology, nuclear medicine, and imaging. With an impressive impact factor reflecting its relevance, the journal has achieved a quartile ranking of Q2 in both Medicine (Miscellaneous) and Radiology, Nuclear Medicine, and Imaging as of 2023. Renowned for disseminating high-quality research, Tomography welcomes original research articles, reviews, and technical notes, fostering innovation and collaboration within the scientific community. Housed in Basel, Switzerland, the journal aims to bridge the gap between fundamental research and clinical application, appealing to a diverse readership eager to advance the field of medical imaging.

EJNMMI Research

Unlocking Innovation in Imaging Science.
Publisher: SPRINGERISSN: 2191-219XFrequency: 1 issue/year

EJNMMI Research, a prominent journal published by Springer, plays a pivotal role in advancing the fields of radiology, nuclear medicine, and imaging. With an impact factor that reflects its strong standing—ranking in the top 22% of its category (Q1 as of 2023)—this open-access journal offers researchers, professionals, and students unparalleled access to innovative research and developments in the field since its inception in 2011. Based in Germany, EJNMMI Research fosters global collaboration by ensuring that cutting-edge findings are freely accessible, thereby accelerating scientific discovery and application. With an emphasis on high-quality, peer-reviewed articles, it serves as an essential resource for those seeking to stay at the forefront of nuclear medicine and imaging. By bridging theoretical insights with practical applications, the journal not only influences academic discourse but also supports ongoing advancements in clinical practices.

EUROPEAN JOURNAL OF RADIOLOGY

Innovating Radiology for a Healthier Future
Publisher: ELSEVIER IRELAND LTDISSN: 0720-048XFrequency: 12 issues/year

The European Journal of Radiology, published by Elsevier Ireland Ltd, is a premier peer-reviewed journal in the fields of radiology, nuclear medicine, and imaging. Established in 1981, it has carved a significant niche within the academic community, showcasing innovative research that enhances medical imaging practices and improves patient care. With an impressive ranking in the Q1 category for both Medicine (miscellaneous) and Radiology, Nuclear Medicine, and Imaging in 2023, the journal is recognized globally for its commitment to advancing scientific knowledge and improving imaging methodologies. The journal's Scopus ranking of #60/333, placing it in the 82nd percentile, underlines its reputation for high-quality research and scholarly contributions. While traditionally a subscription-based journal, it continually evolves to meet the demands of the academic landscape, aiming to bridge the gap between research and clinical practice. Researchers, healthcare professionals, and students alike can benefit from exploring its extensive archives and current publications, which are curated to foster education and innovation in the medical imaging domain.

NUCLEAR MEDICINE REVIEW

Pioneering Insights in Nuclear Imaging
Publisher: VIA MEDICAISSN: 1506-9680Frequency: 2 issues/year

NUCLEAR MEDICINE REVIEW is a distinguished journal in the field of radiology, nuclear medicine, and imaging, published by VIA MEDICA in Poland. Since its transition to an open access format in 1999, this journal has been dedicated to promoting the dissemination of knowledge and research findings across a global audience. With a focus on innovative approaches and advancements in nuclear medicine, it aims to serve as a key resource for researchers, professionals, and students who are working to further the understanding of nuclear imaging and its applications. In 2023, the journal was classified in the Q3 category within Radiology, Nuclear Medicine and Imaging, and Q4 in the broader category of Medicine (miscellaneous), highlighting its growing reputation in the academic community. As of the latest assessments, the journal has been ranked #235 out of 333 in its field according to Scopus metrics, reflecting its commitment to excellence and the relevance of its published works. The NUCLEAR MEDICINE REVIEW is a pivotal platform for those engaged in cutting-edge research, providing insights that drive the evolution of medical imaging and therapeutic techniques.

QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Unveiling Breakthroughs in Nuclear Medicine and Molecular Imaging.
Publisher: EDIZIONI MINERVA MEDICAISSN: 1824-4785Frequency: 4 issues/year

The Quarterly Journal of Nuclear Medicine and Molecular Imaging, published by Edizioni Minerva Medica in Italy, serves as a pivotal platform for researchers and practitioners in the fields of Nuclear Medicine and Molecular Imaging. With an ISSN of 1824-4785 and an E-ISSN of 1827-1936, this journal boasts a respectable impact factor and is positioned in the Q3 quartile of the Radiology, Nuclear Medicine and Imaging category, based on the latest 2023 evaluations. As the journal continues to converge from its inception in 2004 to its anticipated expansions through 2024, it aims to disseminate high-quality, peer-reviewed articles that advance the frontier of imaging technologies and their applications in clinical practice. Researchers, professionals, and students are encouraged to contribute to its diverse scope, which encompasses innovative research, clinical findings, and reviews that encapsulate cutting-edge advancements in the field, highlighting its importance as an essential resource for knowledge and collaboration.

Imaging

Empowering Collaboration in Medical Imaging
Publisher: AKADEMIAI KIADO ZRTISSN: Frequency: 2 issues/year

Imaging, published by AKADEMIAI KIADO ZRT, is an esteemed open-access journal dedicated to the field of medical imaging, established in 2020. With an E-ISSN of 2732-0960 and based in Budapest, Hungary, this journal provides a vital platform for the dissemination of cutting-edge research and advancements in imaging techniques, especially in the realms of radiology, nuclear medicine, and ultrasound technology. While currently positioned in the Q4 category across multiple medical specialties, the journal continues to strive for improvements in visibility and impact, contributing to the evolving discourse in medical imaging. The journal aims to facilitate an inclusive and collaborative environment for researchers, professionals, and students, inviting them to share their findings and insights to enhance the field's development. With open-access availability since its inception, Imaging ensures free and easy access to its content, fostering a greater understanding and appreciation of innovative imaging practices worldwide.

Radiology-Imaging Cancer

Enhancing Cancer Treatment through Radiological Innovations.
Publisher: RADIOLOGICAL SOC NORTH AMERICA (RSNA)ISSN: 2638-616XFrequency: 6 issues/year

Radiology-Imaging Cancer is a prestigious journal published by the Radiological Society of North America (RSNA), focusing on the critical intersection of radiology, oncology, and advanced imaging techniques. This journal stands out in its field with a commendable ranking in the Q2 category for Medicine (miscellaneous) and Oncology, and an impressive Q1 ranking in Radiology, Nuclear Medicine and Imaging, according to the 2023 quartiles. With an ISSN of 2638-616X, it serves as an essential platform for the dissemination of research that contributes to the understanding and improvement of cancer diagnosis and treatment. Its comprehensive scope encompasses a range of topics, from innovative imaging modalities to clinical applications in oncology, making it a valuable resource for researchers, clinicians, and students interested in the evolving field of cancer imaging. Despite being published in the United States, the journal aims for a global reach, catering to a wide audience dedicated to advancing medical science.

Medecine Nucleaire-Imagerie Fonctionnelle et Metabolique

Illuminating the Path of Functional Imaging.
Publisher: ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIERISSN: 0928-1258Frequency: 6 issues/year

Medicine Nucleaire-Imagerie Fonctionnelle et Metabolique is a prominent journal published by Elsevier France-Editions Scientifiques Medicales Elsevier, dedicated to the specialized fields of nuclear medicine and functional imaging. With an ISSN of 0928-1258 and an E-ISSN of 1878-6820, this esteemed publication has been a crucial platform for the dissemination of research and developments in the discipline since its inception in 1993. Covering a wide array of topics within biophysics, radiological and ultrasound technology, and radiology, the journal currently holds a Q4 category ranking in these fields, reflecting its significance within the academic community. Although there are currently no open access options available for readers, the journal caters to a niche audience of researchers, professionals, and students who seek to enhance their understanding of metabolic imaging and its applications. The 2023 Scopus ranks indicate its position as an emerging source of knowledge in a competitive landscape, making it an important resource for the latest studies and innovations in nuclear medicine.

ANNALS OF NUCLEAR MEDICINE

Advancing the Frontiers of Nuclear Medicine
Publisher: SPRINGERISSN: 0914-7187Frequency: 10 issues/year

ANNALS OF NUCLEAR MEDICINE is a prominent academic journal dedicated to the field of nuclear medicine, published by Springer. With a rich publication history dating back to 1987 and continuing through 2024, this journal serves as a vital resource for researchers and practitioners interested in the latest developments in nuclear imaging, radiopharmaceuticals, and therapeutic applications. Ranked in the second quartile (Q2) for both Medicine (miscellaneous) and Radiology, Nuclear Medicine, and Imaging categories in 2023, it maintains a strong position in the academic community, with an impressive Scopus rank of #104 out of 333 in its field, placing it in the 68th percentile. The journal is not open access but offers a range of access options through institutional or individual subscriptions, ensuring that critical research findings reach a wide audience. By fostering high-quality, peer-reviewed articles, ANNALS OF NUCLEAR MEDICINE plays a crucial role in advancing the understanding and practical application of nuclear medicine techniques, making it an essential journal for professionals and students aiming to stay at the forefront of this evolving discipline.